Search

Your search keyword '"Loftus, E"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Loftus, E" Remove constraint Author: "Loftus, E" Database Complementary Index Remove constraint Database: Complementary Index
37 results on '"Loftus, E"'

Search Results

5. Immune modulator therapy for microscopic colitis in a case series of 73 patients.

6. Comparative effectiveness and safety of infliximab and adalimumab in patients with ulcerative colitis.

7. Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease.

8. Systematic review with meta-analysis: faecal diversion for management of perianal Crohn's disease.

9. Systematic review: colitis associated with anti- CTLA-4 therapy.

10. Efficacy and safety of certolizumab pegol for Crohn's disease in clinical practice.

11. Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7-year PRECiSE 3 study.

12. Letter: comparative efficacy of biological therapy in patients with ulcerative colitis.

13. Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn's colitis.

14. The fate of indefinite and low-grade dysplasia in ulcerative colitis and primary sclerosing cholangitis colitis before and after liver transplantation.

15. Meta-analysis: serological markers and the risk of acute and chronic pouchitis.

16. Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease.

17. Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients.

18. Evolving Molecular Targets in the Treatment of Nonmalignant Gastrointestinal Diseases.

19. Die Rolle der D�nndarmendoskopie beim Management von Patienten mit chronisch-entz�ndlichen Darmerkrankungen: ein internationaler OMED-ECCO-Konsensus.

20. Age at onset of inflammatory bowel disease and the risk of surgery for non-neoplastic bowel disease.

21. Systematic review Short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis.

22. Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial.

23. The epidemiology and natural history of Crohn’s disease in population-based patient cohorts from North America: a systematic review.

26. Interexaminer agreement in the measurement of periodontal disease.

30. Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease.

32. FORUM.

34. Letter: cytomegalovirus colitis in a patient treated with ipilimumab for metastatic melanoma - authors' reply.

36. Letter: effectiveness of split-dose certolizumab pegol for Crohn's disease.

37. Markov model projection of remission status for early versus delayed step-up adalimumab use in moderate to severe crohn's disease.

Catalog

Books, media, physical & digital resources